Company
Vivtex
Overcome medical boundaries through technological innovation
Also known as VIVTEX CORP
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- pharma and biotech partnerships
- Legal name
- VIVTEX CORP
Claim, correct or request removal
Record updated 28 September 2026
About
Explore how we use the entire gastrointestinal tract outside the body for automated high throughput screening combined with AI.
Funding snapshot
- Total raised
- $1.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $1.8M2022-05-05
Funding rounds
- Round, 2022
- $1.8M2022-05-05, SEC form D sold, 14 investors
Loading relationship preview